15-ADON	15-acetyldeoxynivalenol
3-ADON	3-acetyldeoxynivalenol
AOP	Adverse Outcome Pathway
BMDL	Benchmark dose (lower confidence limit)
bw	Body weight
CerS	Ceramide synthase
crt	Creatinine
DG SANTE	Directorate-General for Health and Food Safety
DOM-1	Deepoxy-deoxynivalenol
DON	Deoxynivalenol
DON-15-GlcA	Deoxynivalenol-15-glucuronide
DON-15-GlcA (fabs_excr)	DON-15-GlcA residence time and excreted fraction
DON-3G	Deoxynivalenol-3-glucoside
DON-3-GlcA	Deoxynivalenol-3-glucuronide
EFSA	European Food Safety Authority
EU	European
FB1–4	Fumonisins B1,2,3,4
fDON	free DON
HBM	Human Biomonitoring
HBM4EU	European Human Biomonitoring Initiative
HBM-GV	Human Biomonitoring Guidance Value
HDAC	Histone deacetylase
HFB1	Hydrolysed FB1
HQ	Hazard quotient
IARC	International Agency for Research on Cancer
ICI	Interlaboratory comparison investigation
LC-MS-MS	Liquid Chromatography with tandem Mass Spectrometry
LOQ	Limit of Quantification
MAPK	Mitogen-activated protein kinases
MIE	Molecular Initiating Event
NCM-FB1	N-(carboxymethyl)-FB1
NDF-FB1	N-(1-deoxy-D-fructos-1-yl)-FB1
NTDs	Neural Tube Defects
pHFB1	Partially hydrolysed FB1
QA/QC	Quality Assurance/Quality Control
RA	Risk assessment
RDF	Reverse Dosimetry Factor
Sa	Sphinganine
So	Sphingosine
SWOT	Strengths, weaknesses, opportunities, threats
TDI	Tolerable daily intake
tDON	total DON
TK	Toxicokinetics